Skip to main navigation Skip to search Skip to main content

Subclinical granulomas in benign skin lesions heralding the onset of BRAF and MEK inhibitor–associated granulomatous dermatitis in a patient with metastatic melanoma

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)722-724
Number of pages3
JournalJAAD Case Reports
Volume4
Issue number7
DOIs
StatePublished - Aug 2018

Keywords

  • BRAF inhibitors
  • MEK inhibitors
  • cutaneous drug reactions
  • drug reactions
  • granulomatous dermatitis
  • melanoma

Cite this